z-logo
open-access-imgOpen Access
Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats
Author(s) -
Gemma Òdena,
Mireia Miquel,
Anna Serafín,
Amparo Galán,
Rosa Morillas,
Ramón Planas,
Ramón Bartolı́
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i17.2084
Subject(s) - rifaximin , cirrhosis , hyperammonemia , medicine , hepatic encephalopathy , ascites , cerebral edema , gastroenterology , liver function , glutamine , endocrinology , biology , biochemistry , amino acid , antibiotics , microbiology and biotechnology
To compare rifaximin and insulin-like growth factor (IGF)-1 treatment of hyperammonemia and brain edema in cirrhotic rats with portal occlusion.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here